DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
Lavigne-Lissalde G, Aya AG, Mercier FJ. , et al.
Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial.
J Thromb Haemost 2015;
13 (04) 520-529
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.